相关实验视频
Updated: Jun 12, 2025

06:41
Veno-Venous Extracorporeal Membrane Oxygenation in a Mouse
Published on: October 24, 2018
12.4K
新出现的静脉动脉外体膜氧化器支持儿科患者耐火性急性心肌炎
Mimoza Maldi1, Guido M Olivieri2, Simone Ghiselli1
1Congenital Cardiac Surgery De Gasperis Cardio Center, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.
Cardiology in the young
|September 27, 2024
概括
由于急性心肌炎导致的儿童严重心力衰竭是罕见但严重的. 静脉动脉外体膜氧化 (VA-ECMO) 对于心脏性休克的生存至关重要,这项研究研究了VA-ECMO的结果.
科学领域:
- 儿童心脏病学 儿童心脏病学
- 心血管外科心血管外科
- 关键护理医学 关键护理医学
背景情况:
- 急性心肌炎可能会导致儿童严重心力衰竭.
- 耐火性心脏性休克需要机械循环支持.
- 静脉动脉外体膜氧化 (VA-ECMO) 是一个关键的干预措施.
研究的目的:
- 评估患者的短期和长期结果.
- 分析VA-ECMO在儿科急性心肌炎中的有效性.
- 提供VA-ECMO后的生存和恢复数据.
主要方法:
- 对患有急性心肌炎的儿科患者的回顾性分析.
- 包括需要VA-ECMO用于心脏性休克的患者.
- 评估住院,短期和长期的结果.
主要成果:
- 在VA-ECMO支持的住院死亡率约为30%.
- 在儿科心脏性休克中,VA-ECMO有效地恢复了输液.
- 进一步分析了短期和长期结果.
结论:
- VA-ECMO是儿童急性心肌炎与耐火性心脏性休克的重要治疗方法.
- 了解VA-ECMO结果对于患者管理至关重要.
- 这项研究有助于了解VA-ECMO在儿科重症监护中的作用.
相关概念视频
Myocarditis III: Medical Management
2
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
2
Acute Respiratory Failure-V
124
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
124
Cardiopulmonary Resuscitation IV: Pharmacological Management
2
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
2

